Albuterol sulfate inhalation solution

Nephron Pharmaceuticals Corp

Nephron Pharmaceuticals Corp, Orlando, Fla, introduces its newest medication, the first FDA-approved generic version of Albuterol Sulfate Inhalation Solution, 0.042%. Therapists and patients no longer need to use multi-dose bottles to measure pediatric dose strengths. For use in children ages 2 to 12. Each vial contains 1.50 mg of albuterol sulfate (equivalent to 1.25 mg albuterol). Preservative- and additive-free; sterile prediluted with normal saline. Thirty unit-dose vials, individually foil wrapped and bar-coded. (800) 443-4313; www.nephronpharm.com.